US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avidity Biosciences, Inc.

69.80

-0.0500-0.07%

Pre-market: 69.65-0.1500-0.21%07:00 EST

Volume:6.04M

Turnover:421.32M

Market Cap:10.26B

PE:-19.57

High:69.88

Open:69.77

Low:69.75

Close:69.85

52wk High:70.51

52wk Low:21.51

Shares:147.00M

Float Shares:113.00M

Volume Ratio:0.21

T/O Rate:5.34%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.5671

EPS(LYR):-2.8885

ROE:-37.76%

ROA:-24.01%

PB:8.60

PE(LYR):-24.16

Loading ...

Overview Company News Filings

Avidity Says Potential Duchenne Muscular Dystrophy Treatment Shows Disease Reversal in Phase 1/2 Trial

MT Newswires Live

BRIEF-Avidity Biosciences' Del-zota Shows Disease Reversal in Key Endpoints

Avidity Biosciences Announces Groundbreaking Results in DMD Trial, Plans BLA Submission for Del-Zota by End of 2025

Avidity Biosciences' Del-Zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in Explore44® and Explore44-Ole™ Phase 1/2 Trial in People Living With Dmd44

THOMSON REUTERS

Director Troy Edward Wilson Reports Disposal of Common Shares of Avidity Biosciences Inc

Novartis to buy U.S. biotech in latest deal targeting firms in $1 billion to $3 billion range

Sarah Boyce, President and CEO, Reports Disposal of Common Shares in Avidity Biosciences Inc

Eric Mosbrooker, Chief Commercial Officer, Reports Disposal of Avidity Biosciences Inc. Common Shares

Wave Life Sciences Says RNA-Editing Therapy Achieves 'Durable' Serum AAT Protein Production

MT Newswires Live

Chief Program Officer Kathleen P. Gallagher Reports Disposal of Common Shares in Avidity Biosciences Inc

Korro to Participate in Upcoming Investor and Scientific Conferences

Sarah Boyce, President and CEO, Reports Disposal of Common Shares of Avidity Biosciences Inc

Avidity Biosciences Inc.'s Chief Medical Officer Steven George Hughes Reports Disposal of Common Shares

Ionis Pharma Wins FDA Nod For First RNA-Targeted Therapy For Rare Genetic Swelling Disorder

Benzinga_recent_news

Avidity Biosciences Inc. Chief Medical Officer Steven George Hughes Reports Disposal of Common Shares

Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates

Calendar of U.S. Earnings Expected in the Week Ahead

Chief Medical Officer Steven George Hughes Reports Disposal of Avidity Biosciences Common Shares

Avidity Biosciences : Barclays Raises Target Price to $62 From $59

THOMSON REUTERS

Avidity Biosciences Q2 EPS $(1.21) Misses $(1.00) Estimate, Sales $3.85M Beat $1.46M Estimate

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RNA/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNA\",,,,,undefined,":{"symbol":"RNA","market":"US","secType":"STK","nameCN":"Avidity Biosciences, Inc.","latestPrice":69.8,"timestamp":1762203600000,"preClose":69.85,"halted":0,"volume":6035086,"hourTrading":{"tag":"盘前","latestPrice":69.65,"preClose":69.8,"latestTime":"07:00 EST","volume":1,"amount":69.65,"timestamp":1762257600104},"delay":0,"floatShares":112999999,"shares":147000000,"eps":-3.567144,"marketStatus":"Pre-Mkt","change":-0.05,"latestTime":"11-04 07:15:37 EST","open":69.77,"high":69.88,"low":69.75,"amount":421316595.7632,"amplitude":0.001861,"askPrice":69.79,"askSize":286,"bidPrice":69.62,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-3.567144,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1762266600000},"marketStatusCode":1,"adr":0,"listingDate":1591934400000,"exchange":"NASDAQ","adjPreClose":69.8,"preHourTrading":{"tag":"盘前","latestPrice":69.65,"preClose":69.8,"latestTime":"07:00 EST","volume":1,"amount":69.65,"timestamp":1762257600104},"postHourTrading":{"tag":"盘后","latestPrice":69.61,"preClose":69.8,"latestTime":"19:37 EST","volume":13997,"amount":975840.4351,"timestamp":1762216638667},"volumeRatio":0.2057537810722228,"impliedVol":0.094,"impliedVolPercentile":0.004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNA\",,,,,undefined,":{"symbol":"RNA","floatShares":112999999,"roa":"-24.01%","roe":"-37.76%","lyrEps":-2.888476,"volumeRatio":0.2057537810722228,"shares":147000000,"dividePrice":0,"high":69.88,"amplitude":0.001861,"preClose":69.85,"low":69.75,"week52Low":21.51,"pbRate":"8.60","psRate":"956.34","week52High":70.51,"institutionHeld":0,"latestPrice":69.8,"committee":-0.993031,"eps":-3.567144,"divideRate":0,"volume":6035086,"delay":0,"ttmEps":-3.567144,"open":69.77,"prevYearClose":29.08,"prevWeekClose":69.85,"prevMonthClose":69.85,"prevQuarterClose":43.57,"fiveDayClose":70,"twentyDayClose":46.18,"sixtyDayClose":46.29},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-07","symbol":"RNA","fiscalQuarterEnding":"2025/06","expectedEps":-0.95,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-1.21},{"market":"US","date":"2025-05-08","symbol":"RNA","fiscalQuarterEnding":"2025/03","expectedEps":-0.88,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.9},{"market":"US","date":"2025-02-27","symbol":"RNA","fiscalQuarterEnding":"2024/12","expectedEps":-0.84,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.8},{"market":"US","date":"2024-11-07","symbol":"RNA","fiscalQuarterEnding":"2024/09","expectedEps":-0.79,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2024-08-09","symbol":"RNA","fiscalQuarterEnding":"2024/06","expectedEps":-0.76,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":-0.65}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0667,"buy":0.3333,"hold":0.6,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6,"analysts":15,"updateTime":1761886800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNA","date":"2025-11-03","current":-19.567475,"percent":0.073171,"low":-34.248987,"twenty":-15.932922,"median":-10.662431,"eighty":-5.130245,"high":-1.864956,"avg":-11.354892,"sd":6.667081,"marketCap":10034185589},"quantilePoints":[{"date":"2020-11-06","current":-31.147883,"twenty":-37.152541,"median":-33.245062,"eighty":-31.420435,"marketCap":1049995135},{"date":"2020-11-13","current":-28.475809,"twenty":-37.148136,"median":-33.185075,"eighty":-31.147883,"marketCap":1095777625},{"date":"2020-11-20","current":-28.924401,"twenty":-37.112735,"median":-32.711956,"eighty":-30.969768,"marketCap":1113039875},{"date":"2020-11-27","current":-29.967864,"twenty":-36.97474,"median":-32.628465,"eighty":-30.631349,"marketCap":1153193370},{"date":"2020-12-04","current":-31.71347,"twenty":-36.937348,"median":-32.283367,"eighty":-30.353044,"marketCap":1220366040},{"date":"2020-12-11","current":-31.37215,"twenty":-36.722887,"median":-32.366858,"eighty":-30.408705,"marketCap":1207231719},{"date":"2020-12-18","current":-28.007714,"twenty":-36.620708,"median":-32.261103,"eighty":-30.184146,"marketCap":1077764842},{"date":"2020-12-24","current":-28.778121,"twenty":-36.497064,"median":-32.160913,"eighty":-30.079555,"marketCap":1107410880},{"date":"2020-12-31","current":-24.887077,"twenty":-36.316609,"median":-32.105252,"eighty":-29.407768,"marketCap":957679623},{"date":"2021-01-08","current":-27.451851,"twenty":-36.149868,"median":-32.005062,"eighty":-29.207279,"marketCap":1056374662},{"date":"2021-01-15","current":-25.803764,"twenty":-36.130188,"median":-31.860343,"eighty":-29.125292,"marketCap":992954656},{"date":"2021-01-22","current":-25.238149,"twenty":-36.089914,"median":-31.826947,"eighty":-28.936103,"marketCap":971189210},{"date":"2021-01-29","current":-22.312552,"twenty":-35.97035,"median":-31.754588,"eighty":-28.475809,"marketCap":858609317},{"date":"2021-02-05","current":-21.883465,"twenty":-35.92353,"median":-31.737889,"eighty":-28.025268,"marketCap":842097599},{"date":"2021-02-12","current":-21.727433,"twenty":-35.862817,"median":-31.708982,"eighty":-27.465504,"marketCap":836093338},{"date":"2021-02-19","current":-25.228397,"twenty":-35.799127,"median":-31.653595,"eighty":-26.778963,"marketCap":970813943},{"date":"2021-02-26","current":-23.531551,"twenty":-35.746052,"median":-31.486779,"eighty":-26.086572,"marketCap":905517606},{"date":"2021-03-05","current":-22.390568,"twenty":-35.653171,"median":-31.396293,"eighty":-25.940292,"marketCap":861611447},{"date":"2021-03-12","current":-25.004101,"twenty":-35.638406,"median":-31.225808,"eighty":-25.238149,"marketCap":962182818},{"date":"2021-03-19","current":-21.412757,"twenty":-35.321452,"median":-31.064391,"eighty":-25.004101,"marketCap":949762842},{"date":"2021-03-26","current":-17.828429,"twenty":-35.215302,"median":-30.969768,"eighty":-24.887077,"marketCap":790779984},{"date":"2021-04-01","current":-18.989311,"twenty":-35.024232,"median":-30.680331,"eighty":-24.762252,"marketCap":842270886},{"date":"2021-04-09","current":-18.72663,"twenty":-34.718913,"median":-30.446554,"eighty":-23.687583,"marketCap":830619660},{"date":"2021-04-16","current":-17.582695,"twenty":-34.413171,"median":-30.201646,"eighty":-23.329342,"marketCap":779880450},{"date":"2021-04-23","current":-19.048626,"twenty":-34.331602,"median":-30.09464,"eighty":-22.642588,"marketCap":844901808},{"date":"2021-04-30","current":-19.878228,"twenty":-34.264448,"median":-29.967864,"eighty":-22.388618,"marketCap":881698811},{"date":"2021-05-07","current":-18.504392,"twenty":-33.967825,"median":-29.319357,"eighty":-21.984885,"marketCap":820762289},{"date":"2021-05-14","current":-12.366031,"twenty":-33.808477,"median":-29.222013,"eighty":-21.780094,"marketCap":768103629},{"date":"2021-05-21","current":-13.322854,"twenty":-33.708758,"median":-29.156835,"eighty":-21.678673,"marketCap":827535742},{"date":"2021-05-28","current":-14.37657,"twenty":-33.651075,"median":-29.109689,"eighty":-21.248369,"marketCap":892986296},{"date":"2021-06-04","current":-13.528752,"twenty":-33.48787,"median":-28.982913,"eighty":-20.919439,"marketCap":840324930},{"date":"2021-06-11","current":-15.533236,"twenty":-33.342039,"median":-28.773245,"eighty":-20.304412,"marketCap":964831444},{"date":"2021-06-18","current":-16.235714,"twenty":-33.276359,"median":-28.475809,"eighty":-19.944808,"marketCap":1008465147},{"date":"2021-06-25","current":-17.719396,"twenty":-33.251868,"median":-28.20763,"eighty":-18.985306,"marketCap":1100622536},{"date":"2021-07-02","current":-14.3039,"twenty":-33.243701,"median":-27.69565,"eighty":-18.607999,"marketCap":888472464},{"date":"2021-07-09","current":-15.266779,"twenty":-33.225889,"median":-27.520114,"eighty":-18.486902,"marketCap":948280729},{"date":"2021-07-16","current":-13.777042,"twenty":-33.198433,"median":-27.183671,"eighty":-17.913165,"marketCap":855747187},{"date":"2021-07-23","current":-13.316798,"twenty":-33.073753,"median":-26.730203,"eighty":-17.637375,"marketCap":827159589},{"date":"2021-07-30","current":-11.693832,"twenty":-32.854637,"median":-26.218224,"eighty":-17.10309,"marketCap":726350689},{"date":"2021-08-06","current":-14.746344,"twenty":-32.752871,"median":-26.067068,"eighty":-16.259938,"marketCap":915954440},{"date":"2021-08-13","current":-11.436404,"twenty":-32.71307,"median":-25.872028,"eighty":-15.828761,"marketCap":891021641},{"date":"2021-08-20","current":-11.81156,"twenty":-32.688579,"median":-25.374677,"eighty":-15.39153,"marketCap":920250439},{"date":"2021-08-27","current":-11.881902,"twenty":-32.635144,"median":-25.223521,"eighty":-15.121439,"marketCap":925730839},{"date":"2021-09-03","current":-11.278135,"twenty":-32.554492,"median":-25.004101,"eighty":-14.763154,"marketCap":878690742},{"date":"2021-09-10","current":-13.224258,"twenty":-32.484973,"median":-24.974845,"eighty":-14.543711,"marketCap":1030315132},{"date":"2021-09-17","current":-14.044912,"twenty":-32.416953,"median":-24.862697,"eighty":-14.441383,"marketCap":1094253128},{"date":"2021-09-24","current":-13.734236,"twenty":-32.283367,"median":-24.779805,"eighty":-14.366881,"marketCap":1070048029},{"date":"2021-10-01","current":-13.611137,"twenty":-32.278914,"median":-24.024026,"eighty":-14.14795,"marketCap":1060457330},{"date":"2021-10-08","current":-13.441145,"twenty":-32.243291,"median":-23.531551,"eighty":-14.069443,"marketCap":1047213031},{"date":"2021-10-15","current":-12.614629,"twenty":-32.169819,"median":-23.441741,"eighty":-13.946434,"marketCap":982818335},{"date":"2021-10-22","current":-13.001509,"twenty":-32.160913,"median":-22.956183,"eighty":-13.742797,"marketCap":1012960533},{"date":"2021-10-29","current":-13.189087,"twenty":-32.149781,"median":-22.581778,"eighty":-13.630951,"marketCap":1027574932},{"date":"2021-11-05","current":-15.299341,"twenty":-32.09711,"median":-22.410072,"eighty":-13.655687,"marketCap":1191986921},{"date":"2021-11-12","current":-12.166812,"twenty":-32.063778,"median":-22.346684,"eighty":-13.593676,"marketCap":1164923541},{"date":"2021-11-19","current":-13.7195,"twenty":-32.038459,"median":-22.01024,"eighty":-13.566299,"marketCap":1313587294},{"date":"2021-11-26","current":-11.863131,"twenty":-31.949401,"median":-21.834705,"eighty":-13.499763,"marketCap":1135847350},{"date":"2021-12-03","current":-11.363528,"twenty":-31.871476,"median":-21.771317,"eighty":-13.400112,"marketCap":1088012325},{"date":"2021-12-10","current":-11.936602,"twenty":-31.860343,"median":-21.688425,"eighty":-13.322854,"marketCap":1142881912},{"date":"2021-12-17","current":-11.363528,"twenty":-31.849211,"median":-21.545715,"eighty":-13.25624,"marketCap":1088012325},{"date":"2021-12-23","current":-12.543963,"twenty":-31.8314,"median":-21.349205,"eighty":-13.175019,"marketCap":1201034295},{"date":"2021-12-31","current":-11.642718,"twenty":-31.820188,"median":-20.980345,"eighty":-13.050829,"marketCap":1114743662},{"date":"2022-01-07","current":-9.389605,"twenty":-31.771823,"median":-20.760217,"eighty":-12.953442,"marketCap":899017081},{"date":"2022-01-14","current":-8.733263,"twenty":-31.751248,"median":-20.311191,"eighty":-12.90702,"marketCap":836174989},{"date":"2022-01-21","current":-6.965059,"twenty":-31.742342,"median":-20.064799,"eighty":-12.792452,"marketCap":666876520},{"date":"2022-01-28","current":-7.464662,"twenty":-31.737889,"median":-19.933711,"eighty":-12.673256,"marketCap":714711544},{"date":"2022-02-04","current":-7.969164,"twenty":-31.73121,"median":-19.0217,"eighty":-12.607595,"marketCap":763015540},{"date":"2022-02-11","current":-7.85161,"twenty":-31.718785,"median":-18.924175,"eighty":-12.532803,"marketCap":751760240},{"date":"2022-02-18","current":-7.312822,"twenty":-31.708084,"median":-18.658841,"eighty":-12.451927,"marketCap":700173449},{"date":"2022-02-25","current":-8.013246,"twenty":-31.700282,"median":-18.504392,"eighty":-12.34642,"marketCap":767236277},{"date":"2022-03-04","current":-6.42211,"twenty":-31.661669,"median":-18.41632,"eighty":-12.182486,"marketCap":757866723},{"date":"2022-03-11","current":-7.093861,"twenty":-31.575306,"median":-18.040269,"eighty":-12.09334,"marketCap":837139487},{"date":"2022-03-18","current":-7.478298,"twenty":-31.50577,"median":-17.752167,"eighty":-11.945203,"marketCap":882506430},{"date":"2022-03-25","current":-7.004834,"twenty":-31.476164,"median":-17.582695,"eighty":-11.873443,"marketCap":826633458},{"date":"2022-04-01","current":-8.097442,"twenty":-31.444319,"median":-17.294593,"eighty":-11.825906,"marketCap":955571086},{"date":"2022-04-08","current":-7.988182,"twenty":-31.401121,"median":-16.853967,"eighty":-11.719268,"marketCap":942677323},{"date":"2022-04-14","current":-7.373084,"twenty":-31.365146,"median":-16.296273,"eighty":-11.643698,"marketCap":870090214},{"date":"2022-04-22","current":-6.745845,"twenty":-31.314866,"median":-16.08129,"eighty":-11.54955,"marketCap":796070465},{"date":"2022-04-29","current":-6.030185,"twenty":-31.210223,"median":-15.799693,"eighty":-11.378103,"marketCap":711616090},{"date":"2022-05-06","current":-5.726567,"twenty":-31.14343,"median":-15.63013,"eighty":-11.319167,"marketCap":675786469},{"date":"2022-05-13","current":-5.018968,"twenty":-31.101128,"median":-15.299341,"eighty":-11.132571,"marketCap":644435550},{"date":"2022-05-20","current":-5.018968,"twenty":-30.999044,"median":-15.266779,"eighty":-10.917803,"marketCap":644435550},{"date":"2022-05-27","current":-5.670078,"twenty":-30.980006,"median":-15.085104,"eighty":-10.201035,"marketCap":728038000},{"date":"2022-06-03","current":-5.080979,"twenty":-30.969768,"median":-14.994266,"eighty":-9.134905,"marketCap":652397688},{"date":"2022-06-10","current":-4.918202,"twenty":-30.802785,"median":-14.767356,"eighty":-8.321825,"marketCap":631497076},{"date":"2022-06-17","current":-4.976336,"twenty":-30.680331,"median":-14.582469,"eighty":-8.263048,"marketCap":638961580},{"date":"2022-06-24","current":-5.511176,"twenty":-30.671425,"median":-14.503743,"eighty":-8.133739,"marketCap":707635021},{"date":"2022-07-01","current":-5.991757,"twenty":-30.517801,"median":-14.446601,"eighty":-8.061832,"marketCap":769341591},{"date":"2022-07-08","current":-6.615737,"twenty":-30.439875,"median":-14.434107,"eighty":-8.00322,"marketCap":849460606},{"date":"2022-07-15","current":-6.794017,"twenty":-30.3998,"median":-14.37657,"eighty":-7.922142,"marketCap":872351753},{"date":"2022-07-22","current":-6.418079,"twenty":-30.277345,"median":-14.265264,"eighty":-7.829079,"marketCap":824081291},{"date":"2022-07-29","current":-6.313436,"twenty":-30.149145,"median":-14.128281,"eighty":-7.661565,"marketCap":810645183},{"date":"2022-08-05","current":-7.359862,"twenty":-30.102442,"median":-14.079861,"eighty":-7.498145,"marketCap":945006263},{"date":"2022-08-12","current":-7.744765,"twenty":-30.09464,"median":-14.061667,"eighty":-7.476679,"marketCap":1144188352},{"date":"2022-08-19","current":-7.3884,"twenty":-30.072013,"median":-14.02967,"eighty":-7.470415,"marketCap":1091540050},{"date":"2022-08-26","current":-7.741237,"twenty":-30.00349,"median":-13.904228,"eighty":-7.470415,"marketCap":1143667082},{"date":"2022-09-02","current":-7.501308,"twenty":-29.680657,"median":-13.816405,"eighty":-7.464662,"marketCap":1108220700},{"date":"2022-09-09","current":-7.363701,"twenty":-29.434907,"median":-13.754752,"eighty":-7.442192,"marketCap":1087891157},{"date":"2022-09-16","current":-7.349588,"twenty":-29.326183,"median":-13.669756,"eighty":-7.391986,"marketCap":1085806076},{"date":"2022-09-23","current":-6.541592,"twenty":-29.285225,"median":-13.638908,"eighty":-7.361398,"marketCap":966435173},{"date":"2022-09-30","current":-5.761823,"twenty":-29.25994,"median":-13.589311,"eighty":-7.336663,"marketCap":851234432},{"date":"2022-10-07","current":-5.779465,"twenty":-29.212191,"median":-13.561735,"eighty":-7.29548,"marketCap":853840784},{"date":"2022-10-14","current":-5.79005,"twenty":-29.181854,"median":-13.499763,"eighty":-7.22525,"marketCap":855404595},{"date":"2022-10-21","current":-5.020866,"twenty":-29.157157,"median":-13.418819,"eighty":-7.180208,"marketCap":741767665},{"date":"2022-10-28","current":-5.130245,"twenty":-29.152611,"median":-13.388388,"eighty":-7.120264,"marketCap":757927045},{"date":"2022-11-04","current":-4.784465,"twenty":-29.133094,"median":-13.325882,"eighty":-7.077936,"marketCap":706842553},{"date":"2022-11-11","current":-4.987127,"twenty":-29.082383,"median":-13.286519,"eighty":-7.007322,"marketCap":808223767},{"date":"2022-11-18","current":-4.076405,"twenty":-29.01802,"median":-13.240249,"eighty":-6.959181,"marketCap":660630343},{"date":"2022-11-25","current":-4.210829,"twenty":-28.971211,"median":-13.206672,"eighty":-6.908542,"marketCap":682415350},{"date":"2022-12-02","current":-3.908375,"twenty":-28.895145,"median":-13.107021,"eighty":-6.819609,"marketCap":633399084},{"date":"2022-12-09","current":-3.666412,"twenty":-28.776171,"median":-13.032334,"eighty":-6.759911,"marketCap":594186071},{"date":"2022-12-16","current":-7.552337,"twenty":-28.709857,"median":-12.972199,"eighty":-6.729659,"marketCap":1223946832},{"date":"2022-12-23","current":-8.569155,"twenty":-28.475809,"median":-12.939832,"eighty":-6.746629,"marketCap":1388734462},{"date":"2022-12-30","current":-9.098065,"twenty":-28.475809,"median":-12.916512,"eighty":-6.749766,"marketCap":1474450608},{"date":"2023-01-06","current":-8.130447,"twenty":-28.468007,"median":-12.870801,"eighty":-6.757262,"marketCap":1317636573},{"date":"2023-01-13","current":-9.286668,"twenty":-28.349034,"median":-12.790483,"eighty":-6.762237,"marketCap":1505016056},{"date":"2023-01-20","current":-9.212867,"twenty":-28.1852,"median":-12.679109,"eighty":-6.781615,"marketCap":1493055663},{"date":"2023-01-27","current":-9.622875,"twenty":-28.042821,"median":-12.668823,"eighty":-6.805644,"marketCap":1559502288},{"date":"2023-02-03","current":-9.90988,"twenty":-27.820476,"median":-12.614629,"eighty":-6.815441,"marketCap":1606014926},{"date":"2023-02-10","current":-9.319469,"twenty":-27.596211,"median":-12.557946,"eighty":-6.825218,"marketCap":1510331786},{"date":"2023-02-17","current":-10.516691,"twenty":-27.524036,"median":-12.524371,"eighty":-6.862225,"marketCap":1704355931},{"date":"2023-02-24","current":-9.335869,"twenty":-27.492809,"median":-12.493203,"eighty":-6.889742,"marketCap":1512989651},{"date":"2023-03-03","current":-10.035487,"twenty":-27.440149,"median":-12.425244,"eighty":-6.901778,"marketCap":1746124614},{"date":"2023-03-10","current":-8.354767,"twenty":-27.231456,"median":-12.333346,"eighty":-6.912071,"marketCap":1453687685},{"date":"2023-03-17","current":-8.346628,"twenty":-26.878433,"median":-12.20808,"eighty":-6.923154,"marketCap":1452271526},{"date":"2023-03-24","current":-8.15129,"twenty":-26.759459,"median":-12.160132,"eighty":-6.936445,"marketCap":1418283699},{"date":"2023-03-31","current":-6.246745,"twenty":-26.718501,"median":-12.09334,"eighty":-6.923154,"marketCap":1086902385},{"date":"2023-04-06","current":-5.514228,"twenty":-26.630733,"median":-12.022319,"eighty":-6.88645,"marketCap":959448034},{"date":"2023-04-14","current":-6.210119,"twenty":-26.297215,"median":-11.936602,"eighty":-6.814077,"marketCap":1080529667},{"date":"2023-04-21","current":-6.409527,"twenty":-26.086572,"median":-11.881733,"eighty":-6.75164,"marketCap":1115225574},{"date":"2023-04-28","current":-5.921182,"twenty":-26.082671,"median":-11.863131,"eighty":-6.746629,"marketCap":1030256007},{"date":"2023-05-05","current":-4.55822,"twenty":-26.057316,"median":-11.826396,"eighty":-6.654268,"marketCap":793107504},{"date":"2023-05-12","current":-4.123772,"twenty":-26.002705,"median":-11.770068,"eighty":-6.61586,"marketCap":792399372},{"date":"2023-05-19","current":-3.939845,"twenty":-25.912986,"median":-11.705944,"eighty":-6.582075,"marketCap":757056927},{"date":"2023-05-26","current":-4.028298,"twenty":-25.768657,"median":-11.642718,"eighty":-6.532696,"marketCap":774053528},{"date":"2023-06-02","current":-4.006185,"twenty":-25.628229,"median":-11.606396,"eighty":-6.507219,"marketCap":769804377},{"date":"2023-06-09","current":-4.38211,"twenty":-25.425387,"median":-11.536054,"eighty":-6.447533,"marketCap":842039931},{"date":"2023-06-16","current":-4.599557,"twenty":-25.265455,"median":-11.451058,"eighty":-6.417304,"marketCap":883823241},{"date":"2023-06-23","current":-4.297342,"twenty":-25.232298,"median":-11.363528,"eighty":-6.355731,"marketCap":825751522},{"date":"2023-06-30","current":-4.087266,"twenty":-25.224496,"median":-11.343275,"eighty":-6.280747,"marketCap":785384595},{"date":"2023-07-07","current":-3.973015,"twenty":-25.19329,"median":-11.29572,"eighty":-6.217444,"marketCap":763430652},{"date":"2023-07-14","current":-4.083581,"twenty":-25.074315,"median":-11.149175,"eighty":-6.034901,"marketCap":784676403},{"date":"2023-07-21","current":-3.718712,"twenty":-25.0002,"median":-11.00556,"eighty":-5.918732,"marketCap":714565425},{"date":"2023-07-28","current":-3.353844,"twenty":-24.982647,"median":-10.912905,"eighty":-5.893783,"marketCap":644454447},{"date":"2023-08-04","current":-3.449668,"twenty":-24.963143,"median":-10.690816,"eighty":-5.812632,"marketCap":662867431},{"date":"2023-08-11","current":-3.431213,"twenty":-24.910482,"median":-10.45519,"eighty":-5.790085,"marketCap":663902014},{"date":"2023-08-18","current":-3.15932,"twenty":-24.877325,"median":-10.098356,"eighty":-5.73622,"marketCap":611293707},{"date":"2023-08-25","current":-3.036777,"twenty":-24.830515,"median":-9.963181,"eighty":-5.694292,"marketCap":587582921},{"date":"2023-09-01","current":-2.895086,"twenty":-24.795408,"median":-9.92423,"eighty":-5.645386,"marketCap":560167324},{"date":"2023-09-08","current":-2.657658,"twenty":-24.779805,"median":-9.89937,"eighty":-5.620688,"marketCap":514227676},{"date":"2023-09-15","current":-2.79169,"twenty":-24.692038,"median":-9.799178,"eighty":-5.507781,"marketCap":540161349},{"date":"2023-09-22","current":-2.665317,"twenty":-24.321462,"median":-9.686426,"eighty":-5.398782,"marketCap":515709600},{"date":"2023-09-29","current":-2.512138,"twenty":-23.726591,"median":-9.659775,"eighty":-5.29414,"marketCap":486071117},{"date":"2023-10-06","current":-2.385765,"twenty":-23.726591,"median":-9.633125,"eighty":-5.197248,"marketCap":461619369},{"date":"2023-10-13","current":-2.339812,"twenty":-23.531551,"median":-9.508072,"eighty":-5.09849,"marketCap":452727824},{"date":"2023-10-20","current":-2.113872,"twenty":-23.531551,"median":-9.377088,"eighty":-5.020866,"marketCap":409011062},{"date":"2023-10-27","current":-2.021965,"twenty":-23.52765,"median":-9.35022,"eighty":-5.018968,"marketCap":391227972},{"date":"2023-11-03","current":-1.937716,"twenty":-23.457752,"median":-9.319469,"eighty":-4.995462,"marketCap":374926807},{"date":"2023-11-10","current":-2.007807,"twenty":-23.297002,"median":-9.252089,"eighty":-4.97662,"marketCap":406074871},{"date":"2023-11-17","current":-2.172681,"twenty":-23.102463,"median":-9.208767,"eighty":-4.944556,"marketCap":439420436},{"date":"2023-11-24","current":-2.293589,"twenty":-22.944481,"median":-9.098065,"eighty":-4.9058,"marketCap":463873850},{"date":"2023-12-01","current":-2.861491,"twenty":-22.854762,"median":-9.062046,"eighty":-4.817675,"marketCap":578730793},{"date":"2023-12-08","current":-2.949424,"twenty":-22.642588,"median":-9.020164,"eighty":-4.736046,"marketCap":596515094},{"date":"2023-12-15","current":-2.942096,"twenty":-22.478734,"median":-8.888495,"eighty":-4.694967,"marketCap":595033069},{"date":"2023-12-22","current":-3.326804,"twenty":-22.459579,"median":-8.782359,"eighty":-4.625203,"marketCap":672839386},{"date":"2023-12-29","current":-3.418401,"twenty":-22.422449,"median":-8.716971,"eighty":-4.575798,"marketCap":691364699},{"date":"2024-01-05","current":-3.605259,"twenty":-22.40227,"median":-8.619287,"eighty":-4.546011,"marketCap":729156339},{"date":"2024-01-12","current":-4.121866,"twenty":-22.386667,"median":-8.480923,"eighty":-4.474248,"marketCap":833639107},{"date":"2024-01-19","current":-3.821428,"twenty":-22.367163,"median":-8.410527,"eighty":-4.373264,"marketCap":772876079},{"date":"2024-01-26","current":-4.11118,"twenty":-22.291896,"median":-8.346628,"eighty":-4.316264,"marketCap":831478023},{"date":"2024-02-02","current":-4.766927,"twenty":-22.169467,"median":-8.324274,"eighty":-4.333222,"marketCap":964101547},{"date":"2024-02-09","current":-4.912213,"twenty":-21.984885,"median":-8.302651,"eighty":-4.337146,"marketCap":993485202},{"date":"2024-02-16","current":-5.312729,"twenty":-21.873713,"median":-8.279699,"eighty":-4.353363,"marketCap":1074488792},{"date":"2024-02-23","current":-5.709318,"twenty":-21.834705,"median":-8.254149,"eighty":-4.371053,"marketCap":1154698229},{"date":"2024-03-01","current":-6.884704,"twenty":-21.815201,"median":-8.220472,"eighty":-4.38211,"marketCap":1461071871},{"date":"2024-03-08","current":-7.531791,"twenty":-21.785945,"median":-8.189978,"eighty":-4.452135,"marketCap":1598396659},{"date":"2024-03-15","current":-9.017834,"twenty":-21.756689,"median":-8.204249,"eighty":-4.466877,"marketCap":1913764632},{"date":"2024-03-22","current":-9.066741,"twenty":-21.727433,"median":-8.229515,"eighty":-4.485305,"marketCap":1924143831},{"date":"2024-03-28","current":-9.281183,"twenty":-21.696227,"median":-8.254149,"eighty":-4.491202,"marketCap":1969652627},{"date":"2024-04-05","current":-10.661495,"twenty":-21.680623,"median":-8.292436,"eighty":-4.519064,"marketCap":2262582364},{"date":"2024-04-12","current":-11.408564,"twenty":-21.678673,"median":-8.304891,"eighty":-4.535429,"marketCap":2421125493},{"date":"2024-04-19","current":-10.368967,"twenty":-21.46594,"median":-8.326723,"eighty":-4.55415,"marketCap":2200502223},{"date":"2024-04-26","current":-10.7245,"twenty":-21.412757,"median":-8.350698,"eighty":-4.564979,"marketCap":2275953471},{"date":"2024-05-03","current":-11.526166,"twenty":-21.311074,"median":-8.417453,"eighty":-4.569664,"marketCap":2446082844},{"date":"2024-05-10","current":-12.211067,"twenty":-21.136518,"median":-8.528949,"eighty":-4.570559,"marketCap":2591432567},{"date":"2024-05-17","current":-12.011,"twenty":-21.004123,"median":-8.619287,"eighty":-4.575834,"marketCap":2746687402},{"date":"2024-05-24","current":-11.488237,"twenty":-20.980345,"median":-8.728825,"eighty":-4.595074,"marketCap":2627141467},{"date":"2024-05-31","current":-11.316771,"twenty":-20.888986,"median":-8.784409,"eighty":-4.609363,"marketCap":2587930400},{"date":"2024-06-07","current":-10.890196,"twenty":-20.746644,"median":-8.909462,"eighty":-4.626414,"marketCap":2490380917},{"date":"2024-06-14","current":-16.711683,"twenty":-20.65513,"median":-8.938982,"eighty":-4.645017,"marketCap":3821644450},{"date":"2024-06-21","current":-17.463994,"twenty":-20.541673,"median":-9.002785,"eighty":-4.663959,"marketCap":3993683592},{"date":"2024-06-28","current":-18.824523,"twenty":-20.426432,"median":-9.017834,"eighty":-4.66706,"marketCap":4304810763},{"date":"2024-07-05","current":-17.278256,"twenty":-20.304412,"median":-9.028364,"eighty":-4.67213,"marketCap":3951208893},{"date":"2024-07-12","current":-20.575102,"twenty":-20.304412,"median":-9.060735,"eighty":-4.682062,"marketCap":4705134803},{"date":"2024-07-15","current":-20.80263,"twenty":-20.416755,"median":-9.066741,"eighty":-4.685549,"marketCap":4757166310},{"date":"2024-08-02","current":-20.695831,"twenty":-20.57994,"median":-9.068053,"eighty":-4.689037,"marketCap":4732743358},{"date":"2024-08-09","current":-19.442101,"twenty":-20.389364,"median":-9.098065,"eighty":-4.702292,"marketCap":4446039138},{"date":"2024-08-16","current":-21.104668,"twenty":-20.45155,"median":-9.161017,"eighty":-4.704816,"marketCap":5327852349},{"date":"2024-08-23","current":-19.882184,"twenty":-20.693049,"median":-9.212867,"eighty":-4.711267,"marketCap":5019237468},{"date":"2024-08-30","current":-19.782437,"twenty":-20.617905,"median":-9.283926,"eighty":-4.724704,"marketCap":4994056368},{"date":"2024-09-06","current":-18.910228,"twenty":-20.584778,"median":-9.305118,"eighty":-4.728041,"marketCap":4773868141},{"date":"2024-09-13","current":-19.165395,"twenty":-20.528184,"median":-9.335869,"eighty":-4.751474,"marketCap":4838284910},{"date":"2024-09-20","current":-21.178899,"twenty":-20.584778,"median":-9.377088,"eighty":-4.766927,"marketCap":5346591773},{"date":"2024-09-27","current":-19.564385,"twenty":-20.614011,"median":-9.508072,"eighty":-4.767001,"marketCap":4939009311},{"date":"2024-10-04","current":-21.828416,"twenty":-20.69977,"median":-9.611919,"eighty":-4.777499,"marketCap":5510561728},{"date":"2024-10-11","current":-20.515463,"twenty":-20.808388,"median":-9.644811,"eighty":-4.795146,"marketCap":5179108175},{"date":"2024-10-18","current":-22.510409,"twenty":-20.924108,"median":-9.672717,"eighty":-4.8043,"marketCap":5682730182},{"date":"2024-10-25","current":-20.946928,"twenty":-21.062913,"median":-9.717176,"eighty":-4.807671,"marketCap":5288031074},{"date":"2024-10-31","current":-20.051522,"twenty":-21.062913,"median":-9.811478,"eighty":-4.820452,"marketCap":5061986778},{"date":"2024-11-08","current":-19.838416,"twenty":-21.062913,"median":-9.907571,"eighty":-4.84349,"marketCap":5564437571},{"date":"2024-11-15","current":-21.255407,"twenty":-21.084706,"median":-9.93858,"eighty":-4.869368,"marketCap":5961886570},{"date":"2024-11-22","current":-18.103464,"twenty":-21.062913,"median":-9.999334,"eighty":-4.898048,"marketCap":5077804531},{"date":"2024-11-29","current":-18.303385,"twenty":-21.046399,"median":-10.098356,"eighty":-4.902699,"marketCap":5133879910},{"date":"2024-12-06","current":-15.687401,"twenty":-20.980345,"median":-10.127184,"eighty":-4.904602,"marketCap":4400127610},{"date":"2024-12-13","current":-14.360267,"twenty":-20.973662,"median":-10.412078,"eighty":-4.913411,"marketCap":4027882541},{"date":"2024-12-20","current":-13.207532,"twenty":-20.943217,"median":-10.598489,"eighty":-4.922504,"marketCap":3704554292},{"date":"2024-12-27","current":-13.237308,"twenty":-20.928371,"median":-10.661495,"eighty":-4.939713,"marketCap":3712905945},{"date":"2025-01-03","current":-13.262829,"twenty":-20.920948,"median":-10.736574,"eighty":-4.941107,"marketCap":3720064504},{"date":"2025-01-10","current":-12.731125,"twenty":-20.899606,"median":-10.760504,"eighty":-4.946106,"marketCap":3570927857},{"date":"2025-01-17","current":-12.033529,"twenty":-20.875481,"median":-10.849125,"eighty":-4.95057,"marketCap":3375260577},{"date":"2025-01-24","current":-12.816198,"twenty":-20.852067,"median":-10.87291,"eighty":-4.952418,"marketCap":3594789721},{"date":"2025-01-31","current":-13.879606,"twenty":-20.823658,"median":-10.890196,"eighty":-4.960884,"marketCap":3893063013},{"date":"2025-02-07","current":-14.934507,"twenty":-20.811267,"median":-10.956919,"eighty":-4.973416,"marketCap":4188950119},{"date":"2025-02-14","current":-14.045498,"twenty":-20.799109,"median":-11.007295,"eighty":-4.97662,"marketCap":3939593647},{"date":"2025-02-21","current":-13.83707,"twenty":-20.776198,"median":-11.084534,"eighty":-4.979061,"marketCap":3881132082},{"date":"2025-02-28","current":-10.764795,"twenty":-20.703709,"median":-11.126407,"eighty":-4.987294,"marketCap":3469514938},{"date":"2025-03-07","current":-11.319953,"twenty":-20.695136,"median":-11.124394,"eighty":-4.988898,"marketCap":3648443335},{"date":"2025-03-14","current":-11.983857,"twenty":-20.689452,"median":-11.128498,"eighty":-4.99405,"marketCap":3862421231},{"date":"2025-03-21","current":-11.498983,"twenty":-20.669492,"median":-11.149175,"eighty":-5.000402,"marketCap":3706145239},{"date":"2025-03-28","current":-12.144239,"twenty":-20.628729,"median":-11.183518,"eighty":-5.004574,"marketCap":3914112520},{"date":"2025-04-04","current":-10.480747,"twenty":-20.594455,"median":-11.15204,"eighty":-5.011771,"marketCap":3377965658},{"date":"2025-04-11","current":-8.992555,"twenty":-20.563174,"median":-11.12911,"eighty":-5.018968,"marketCap":2898318577},{"date":"2025-04-17","current":-9.607973,"twenty":-20.515463,"median":-11.126407,"eighty":-5.018968,"marketCap":3096668873},{"date":"2025-04-25","current":-11.536281,"twenty":-20.496906,"median":-11.124394,"eighty":-5.020866,"marketCap":3718166469},{"date":"2025-05-02","current":-12.192726,"twenty":-20.420662,"median":-11.12911,"eighty":-5.038508,"marketCap":3929740119},{"date":"2025-05-09","current":-9.341019,"twenty":-20.413396,"median":-11.128576,"eighty":-5.046601,"marketCap":3448890915},{"date":"2025-05-16","current":-9.457766,"twenty":-20.413396,"median":-11.114009,"eighty":-5.080979,"marketCap":3491996260},{"date":"2025-05-23","current":-10.058466,"twenty":-20.390199,"median":-11.032758,"eighty":-5.09849,"marketCap":3713786840},{"date":"2025-05-30","current":-10.349022,"twenty":-20.352383,"median":-11.021568,"eighty":-5.118249,"marketCap":3821065980},{"date":"2025-06-06","current":-11.618981,"twenty":-20.317539,"median":-11.026753,"eighty":-5.128834,"marketCap":4289960196},{"date":"2025-06-13","current":-10.492668,"twenty":-20.231531,"median":-10.995783,"eighty":-5.130468,"marketCap":3874102858},{"date":"2025-06-20","current":-9.572029,"twenty":-20.051522,"median":-10.937395,"eighty":-5.130245,"marketCap":3534184685},{"date":"2025-06-27","current":-9.738528,"twenty":-19.87723,"median":-10.873014,"eighty":-5.130245,"marketCap":3595659248},{"date":"2025-07-03","current":-9.523059,"twenty":-19.748568,"median":-10.832637,"eighty":-5.130245,"marketCap":3516103932},{"date":"2025-07-11","current":-10.273935,"twenty":-19.564385,"median":-10.736574,"eighty":-5.130245,"marketCap":3793342157},{"date":"2025-07-18","current":-11.112956,"twenty":-19.350972,"median":-10.662431,"eighty":-5.130245,"marketCap":4103125740},{"date":"2025-07-25","current":-10.841988,"twenty":-19.163495,"median":-10.662431,"eighty":-5.130245,"marketCap":4003078902},{"date":"2025-08-01","current":-11.984625,"twenty":-18.989311,"median":-10.662431,"eighty":-5.130245,"marketCap":4424963158},{"date":"2025-08-08","current":-15.513739,"twenty":-18.910228,"median":-10.662431,"eighty":-5.130245,"marketCap":5727982819},{"date":"2025-08-15","current":-13.005295,"twenty":-18.745585,"median":-10.662431,"eighty":-5.130245,"marketCap":5927059235},{"date":"2025-08-22","current":-12.60726,"twenty":-18.56711,"median":-10.662431,"eighty":-5.130245,"marketCap":5745658030},{"date":"2025-08-29","current":-13.713854,"twenty":-18.406613,"median":-10.662431,"eighty":-5.130245,"marketCap":6249979111},{"date":"2025-09-05","current":-13.682801,"twenty":-18.313057,"median":-10.661963,"eighty":-5.128834,"marketCap":6235827244},{"date":"2025-09-12","current":-11.585355,"twenty":-18.103464,"median":-10.662431,"eighty":-5.130245,"marketCap":5279932950},{"date":"2025-09-19","current":-13.178829,"twenty":-17.798322,"median":-10.662431,"eighty":-5.130245,"marketCap":6006146019},{"date":"2025-09-26","current":-12.873078,"twenty":-17.582695,"median":-10.662431,"eighty":-5.130245,"marketCap":5866802283},{"date":"2025-10-03","current":-13.925871,"twenty":-17.278256,"median":-10.662431,"eighty":-5.130245,"marketCap":6346604428},{"date":"2025-10-10","current":-16.003089,"twenty":-16.853967,"median":-10.662431,"eighty":-5.130245,"marketCap":7293279919},{"date":"2025-10-17","current":-15.375826,"twenty":-16.235714,"median":-10.662431,"eighty":-5.130245,"marketCap":7007409778},{"date":"2025-10-24","current":-15.303328,"twenty":-16.003089,"median":-10.662431,"eighty":-5.130245,"marketCap":6974369511},{"date":"2025-10-31","current":-21.966817,"twenty":-15.932922,"median":-10.662431,"eighty":-5.130245,"marketCap":10011201055},{"date":"2025-11-03","current":-22.01725,"twenty":-15.932922,"median":-10.662431,"eighty":-5.130245,"marketCap":10034185589}],"updateTime":1762258537156},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNA\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2566605063","title":"Avidity Says Potential Duchenne Muscular Dystrophy Treatment Shows Disease Reversal in Phase 1/2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2566605063","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566605063?lang=en_us&edition=fundamental","pubTime":"2025-09-10 20:05","pubTimestamp":1757505929,"startTime":"0","endTime":"0","summary":"Avidity Biosciences  said Wednesday that new data from 17 DMD44 patients treated continuously with del-zota for one year in a phase 1/2 trial demonstrated reversal of disease progression and \"unprecedented\" improvement compared to baseline and natural history across multiple endpoints.DMD44 is a form of Duchenne muscular dystrophy with mutations amenable to exon 44 skipping.Data from the trial showed that participants treated with del-zota demonstrated \"statistically significant\" increases of approximately 25% of normal in dystrophin production and over 80% reduction in creatine kinase levels compared to baseline, the company said.Avidity said it remains on track to submit a biologics license application for del-zota to the US Food and Drug Administration by the end of 2025.The company said it is also preparing a confirmatory study to support global approval.Shares of the company were up 1.4% in recent premarket activity Wednesday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4505","RNA","BK4139","BK4585"],"gpt_icon":0},{"id":"2566605977","title":"BRIEF-Avidity Biosciences' Del-zota Shows Disease Reversal in Key Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2566605977","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566605977?lang=en_us&edition=fundamental","pubTime":"2025-09-10 19:48","pubTimestamp":1757504892,"startTime":"0","endTime":"0","summary":"BRIEF-Avidity Biosciences' Del-zota Shows Disease Reversal in Key Endpoints Sept 10 (Reuters) - Avidity Biosciences Inc RNA.O:AVIDITY BIOSCIENCES' DEL-ZOTA DEMONSTRATED REVERSAL OF DISEASE PROGRESSION","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nTUA3Z84XZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA","BK4505","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2566608526","title":"Avidity Biosciences Announces Groundbreaking Results in DMD Trial, Plans BLA Submission for Del-Zota by End of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2566608526","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566608526?lang=en_us&edition=fundamental","pubTime":"2025-09-10 19:00","pubTimestamp":1757502048,"startTime":"0","endTime":"0","summary":"Avidity Biosciences Inc., a biopharmaceutical company, has announced positive new data from its EXPLORE44 and EXPLORE44-OLE trials involving the treatment of participants with del-zota for one year. The data demonstrated a reversal of disease progression and significant improvement in multiple functional measures such as Time to Rise from Floor , 4-Stair Climb , Performance of Upper Limb , and the 10-Meter Walk/Run Test . Additionally, there was a rapid reduction in creatine kinase  levels and a 25% increase in normal dystrophin production. Avidity remains on schedule to submit a Biologics License Application  for accelerated FDA approval by the end of 2025. Further data from the EXPLORE44 program will be presented at upcoming scientific congresses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nNDL7nYhJ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","BK4588","RNA","BK4505"],"gpt_icon":0},{"id":"2566331608","title":"Avidity Biosciences' Del-Zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in Explore44® and Explore44-Ole™ Phase 1/2 Trial in People Living With Dmd44","url":"https://stock-news.laohu8.com/highlight/detail?id=2566331608","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566331608?lang=en_us&edition=fundamental","pubTime":"2025-09-10 19:00","pubTimestamp":1757502005,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nTUA3Z84XZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNA","BK4505","BK4139","BK4588","BK4585"],"gpt_icon":0},{"id":"2566464645","title":"Director Troy Edward Wilson Reports Disposal of Common Shares of Avidity Biosciences Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2566464645","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566464645?lang=en_us&edition=fundamental","pubTime":"2025-09-10 05:53","pubTimestamp":1757454832,"startTime":"0","endTime":"0","summary":"Troy Edward Wilson, a Director at Avidity Biosciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avidity Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 09, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nNDL2flqdS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","BK4505","BK4585","RNA"],"gpt_icon":0},{"id":"2566933226","title":"Novartis to buy U.S. biotech in latest deal targeting firms in $1 billion to $3 billion range","url":"https://stock-news.laohu8.com/highlight/detail?id=2566933226","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566933226?lang=en_us&edition=fundamental","pubTime":"2025-09-09 17:39","pubTimestamp":1757410740,"startTime":"0","endTime":"0","summary":"Novartis said it was buying a U.S.-listed biotech.Novartis on Tuesday said it was buying a U.S. biotech working on a cardiovascular drug, continuing what's been a flurry of acquisitions at a similar price point.Novartis said it was purchasing Tourmaline Bio for $48 per share, which had closed Monday at $30.18, valuing the New York company at $1.4 billion.Tourmaline shares  rocketed 56% to $47.10. Tourmaline has a drug in Phase 2 development to treat atherosclerotic cardiovascular disease, which Novartis calls a \"critical unmet need.\". According to FactSet, Novartis has bought several companies in the $1 billion to $3 billion range, including Regulus Therapeutics, Anthos Therapeutics, Kate Therapeutics, Mariana Oncology, MorphoSys, DTx Pharma and Chinook Therapeutics.Last month, the Financial Times reported Novartis was considering bidding for Avidity , a biotech developing treatments for rare muscle disorders.This content was created by MarketWatch, which is operated by Dow Jones & Co.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"5fb54e106e0dea5e9f2c2ac0de52d562","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4007","NVS","LU0208291251.USD","BK4578","BK4505","IE00B2B36J28.USD","IE0009355771.USD","IE00BJT1NW94.SGD","TRML","IE00B4R5TH58.HKD","BK4139","IE00BFTCPJ56.SGD","RNA","BK4588","LU0211331839.USD","LU0070302665.USD","BK4532","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0320765489.SGD","BK4539"],"gpt_icon":0},{"id":"2565599752","title":"Sarah Boyce, President and CEO, Reports Disposal of Common Shares in Avidity Biosciences Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2565599752","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565599752?lang=en_us&edition=fundamental","pubTime":"2025-09-06 06:56","pubTimestamp":1757112992,"startTime":"0","endTime":"0","summary":"Avidity Biosciences Inc. reported a disposal of common shares by Sarah Boyce, President and CEO of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avidity Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nNDLmpr3W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4505","BK4139","RNA","BK4588"],"gpt_icon":0},{"id":"2565950599","title":"Eric Mosbrooker, Chief Commercial Officer, Reports Disposal of Avidity Biosciences Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2565950599","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565950599?lang=en_us&edition=fundamental","pubTime":"2025-09-06 06:33","pubTimestamp":1757111596,"startTime":"0","endTime":"0","summary":"Eric Mosbrooker, Chief Commercial Officer of Avidity Biosciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avidity Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nNDLc2tlKP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4505","RNA","BK4139","BK4585"],"gpt_icon":0},{"id":"2564984399","title":"Wave Life Sciences Says RNA-Editing Therapy Achieves 'Durable' Serum AAT Protein Production","url":"https://stock-news.laohu8.com/highlight/detail?id=2564984399","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564984399?lang=en_us&edition=fundamental","pubTime":"2025-09-03 21:35","pubTimestamp":1756906515,"startTime":"0","endTime":"0","summary":"Wave Life Sciences (WVE) said Wednesday that its experimental RNA-editing therapy WVE-006 achieved \"durable\" production of serum AAT protein at levels linked to a lower risk of alpha-1 antitrypsin def","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","RNA","BK4007","BK4160","GSK.UK","AAT","LU1829250122.USD","BK4139","BK4532","WVE","GSK","BK4588","BK4585"],"gpt_icon":0},{"id":"2564332698","title":"Chief Program Officer Kathleen P. Gallagher Reports Disposal of Common Shares in Avidity Biosciences Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2564332698","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564332698?lang=en_us&edition=fundamental","pubTime":"2025-09-03 08:31","pubTimestamp":1756859485,"startTime":"0","endTime":"0","summary":"Kathleen P. Gallagher, Chief Program Officer at Avidity Biosciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avidity Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 02, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nNDL3nnKwY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4505","RNA","BK4585","BK4139"],"gpt_icon":0},{"id":"2564211338","title":"Korro to Participate in Upcoming Investor and Scientific Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2564211338","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564211338?lang=en_us&edition=fundamental","pubTime":"2025-09-03 04:30","pubTimestamp":1756845000,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Sept.  02, 2025  (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and scienti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/02/3143181/0/en/Korro-to-Participate-in-Upcoming-Investor-and-Scientific-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574139.USD","BK4505","LU0267386448.USD","LU1732800096.USD","LU2023251221.USD","LU2357305700.SGD","RNA","LU1989772840.SGD","IE00BKVL7J92.USD","LU0106261372.USD","LU2089284900.SGD","BK4581","LU1162221912.USD","LU2133065610.SGD","BK4127","LU1244550577.SGD","LU0225283273.USD","LU1720051108.HKD","LU2028103732.USD","LU0106831901.USD","LU1732799900.SGD","LU1244550494.USD","LU0234570918.USD","LU0912757837.SGD","LU0971096721.USD","LU1074936037.SGD","IE00BZ1G4Q59.USD","LU1668664300.SGD","BK4585","LU0158827948.USD","LU1244550221.USD","LU0006306889.USD","LU1363072403.SGD","LU0795875086.SGD","LU2271345857.HKD","LU0320765646.SGD","BK4516","BK4139","BK4534","LU2111349929.HKD","BK4504","LU0314104364.USD","BK4588","LU1989772923.USD","LU2347655156.SGD","LU1720051017.SGD","LU1548497426.USD","LU0158827781.USD","LU2089283258.USD","LU0795875169.SGD"],"gpt_icon":0},{"id":"2563745200","title":"Sarah Boyce, President and CEO, Reports Disposal of Common Shares of Avidity Biosciences Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2563745200","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563745200?lang=en_us&edition=fundamental","pubTime":"2025-08-30 04:29","pubTimestamp":1756499345,"startTime":"0","endTime":"0","summary":"Sarah Boyce, President and CEO of Avidity Biosciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avidity Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nNDL5vwPY6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4588","BK4585","BK4139","RNA"],"gpt_icon":0},{"id":"2561283963","title":"Avidity Biosciences Inc.'s Chief Medical Officer Steven George Hughes Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2561283963","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561283963?lang=en_us&edition=fundamental","pubTime":"2025-08-23 05:20","pubTimestamp":1755897644,"startTime":"0","endTime":"0","summary":"Steven George Hughes, the Chief Medical Officer of Avidity Biosciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avidity Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250822:nNDL2pbnBt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA","BK4505","BK4139","BK4585","BK4588"],"gpt_icon":0},{"id":"2561441840","title":"Ionis Pharma Wins FDA Nod For First RNA-Targeted Therapy For Rare Genetic Swelling Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2561441840","media":"Benzinga_recent_news","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561441840?lang=en_us&edition=fundamental","pubTime":"2025-08-22 02:24","pubTimestamp":1755800640,"startTime":"0","endTime":"0","summary":"FDA approved Ionis' Dawnzera for hereditary angioedema, showing up to 87% attack reduction and strong results in switch patients.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/08/21/Woman--Scientist--MedicalResearch.jpeg?optimize=medium&dpr=2&auto=webp&width=120","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/08/21/Woman--Scientist--MedicalResearch.jpeg?optimize=medium&dpr=2&auto=webp&width=120"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/fda/25/08/47267611/ionis-pharma-wins-fda-nod-for-first-rna-targeted-therapy-for-rare-genetic-swelling-disorder","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/fda/25/08/47267611/ionis-pharma-wins-fda-nod-for-first-rna-targeted-therapy-for-rare-genetic-swelling-disorder","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4588","HAE","RNA","BK4198","BK4585","LU0106261612.USD","LU0205193047.USD","IE00B64QTZ34.USD","IE0034390439.USD","BK4139","LU0205194284.USD","IE00BLDYK493.USD","IE00B19Z6F94.USD","LU0012050646.USD","LU1169589451.USD","BK4505","LU1169590202.USD"],"gpt_icon":0},{"id":"2559946814","title":"Avidity Biosciences Inc. Chief Medical Officer Steven George Hughes Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2559946814","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559946814?lang=en_us&edition=fundamental","pubTime":"2025-08-16 04:08","pubTimestamp":1755288492,"startTime":"0","endTime":"0","summary":"Steven George Hughes, the Chief Medical Officer of Avidity Biosciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avidity Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 15, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nNDL8Cc0fG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","RNA","BK4585","BK4505"],"gpt_icon":0},{"id":"2558490826","title":"Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2558490826","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558490826?lang=en_us&edition=fundamental","pubTime":"2025-08-12 19:00","pubTimestamp":1754996400,"startTime":"0","endTime":"0","summary":"—Interim readout from Phase 1/2a REWRITE clinical trial of KRRO-110 on track for the second half of 2025 —Completed dosing of over 80% of planned REWRITE healthy volunteers across multiple single asce","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/12/3131541/0/en/Korro-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EMA","BK4588","BK4505","BK4585","BK4081","RNA"],"gpt_icon":0},{"id":"2558365911","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2558365911","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558365911?lang=en_us&edition=fundamental","pubTime":"2025-08-11 18:00","pubTimestamp":1754906400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·AMC Ent Hldgs                                    2Q      (.07)  4:15 PM. ·Barrick Mining Corp                                2Q       .46   6:00 AM. ·Gaia Inc. Class A                               2Q      (.08)  4:05 PM. ·Green Plains Inc.                               2Q      (.33)  6:55 AM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLDP","MNDY","PNNT","ACXP","CAI","IHRT","RAL","BKV","LPSN","GRWG","AVXL","ASRT","RNA","AIOT","PFLT","DEC","RUM","ADCT","CEVA","DDD","GAIA","BTM","BITF","BHST","CAH","EDRY","EE","NGS","FNV","DSP","LAR","RPAY","COYA","GRDN","CAVA","CE","ARIS","MRCY","CAE","HPK","PAL","MRVI","ARCT","ARQ","ALXO","INR","TLS","BTAI","BW"],"gpt_icon":1},{"id":"2558577954","title":"Chief Medical Officer Steven George Hughes Reports Disposal of Avidity Biosciences Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2558577954","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558577954?lang=en_us&edition=fundamental","pubTime":"2025-08-09 05:40","pubTimestamp":1754689205,"startTime":"0","endTime":"0","summary":"Steven George Hughes, the Chief Medical Officer of Avidity Biosciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avidity Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 08, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nNDLblqJwj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4505","BK4139","BK4588","RNA"],"gpt_icon":0},{"id":"2557547629","title":"Avidity Biosciences : Barclays Raises Target Price to $62 From $59","url":"https://stock-news.laohu8.com/highlight/detail?id=2557547629","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557547629?lang=en_us&edition=fundamental","pubTime":"2025-08-08 17:53","pubTimestamp":1754646823,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nAZN4C1KYS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4585","RNA","BK4505","BK4139"],"gpt_icon":0},{"id":"2557591389","title":"Avidity Biosciences Q2 EPS $(1.21) Misses $(1.00) Estimate, Sales $3.85M Beat $1.46M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557591389","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557591389?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:53","pubTimestamp":1754600000,"startTime":"0","endTime":"0","summary":"Avidity Biosciences (NASDAQ:RNA) reported quarterly losses of $(1.21) per share which missed the analyst consensus estimate of $(1.00) by 21.12 percent. This is a 86.15 percent decrease over losses of $(0.65) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46982237/avidity-biosciences-q2-eps-1-21-misses-1-00-estimate-sales-3-85m-beat-1-46m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Avidity Biosciences Q2 EPS $(1.21) Misses $(1.00) Estimate, Sales $3.85M Beat $1.46M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":195,"code":"91000000","status":"200"}]}}